Elevance Health Inc (NYSE: ELV) is -35.36% lower on its value in year-to-date trading and has touched a low of $357.45 and a high of $567.26 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ELV stock was last observed hovering at around $395.76 in the last trading session, with the day’s gains setting it 1789604.24%.
Currently trading at $1790000.0, the stock is -7.80% and -10.78% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.8 million and changing -11.50% at the moment leaves the stock -15.56% off its SMA200. ELV registered -5.06% loss for a year compared to 6-month gain of -5.61%. The firm has a 50-day simple moving average (SMA 50) of $392.5846 and a 200-day simple moving average (SMA200) of $414.8125.
The stock witnessed a -7.11% loss in the last 1 month and extending the period to 3 months gives it a -19.05%, and is -6.32% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.61% over the week and 2.40% over the month.
Elevance Health Inc (ELV) has around 104200 employees, a market worth around $79.13B and $183.12B in sales. Current P/E ratio is 13.67 and Fwd P/E is 8.94. Profit margin for the company is 3.23%. Distance from 52-week low is -2.01% and -38.26% from its 52-week high. The company has generated returns on investments over the last 12 months (8.38%).
The EPS is expected to grow by 4.36% this year
2230.0 institutions hold shares in Elevance Health Inc (ELV), with institutional investors hold 93.23% of the company’s shares. The shares outstanding are 225.64M, and float is at 225.55M with Short Float at 1.11%. Institutions hold 93.07% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 21.21 million shares valued at $11.49 billion. The investor’s holdings represent 9.133 of the ELV Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 20.7 million shares valued at $11.22 billion to account for 8.9168 of the shares outstanding. The other top investors are PRICE T ROWE ASSOCIATES INC /MD/ which holds 11.65 million shares representing 5.0157 and valued at over $6.31 billion, while STATE STREET CORP holds 4.5471 of the shares totaling 10.56 million with a market value of $5.72 billion.
Elevance Health Inc (ELV) Insider Activity
The most recent transaction is an insider sale by Kaye Mark, the company’s EVP & CFO. SEC filings show that Kaye Mark sold 4,588 shares of the company’s common stock on Apr 24 ’25 at a price of $424.82 per share for a total of $1.95 million. Following the sale, the insider now owns 18977.0 shares.
Still, SEC filings show that on Mar 10 ’25, Penczek Ronald W (CAO & Controller) disposed off 443 shares at an average price of $415.13 for $0.18 million. The insider now directly holds 1,847 shares of Elevance Health Inc (ELV).
